Literature DB >> 8093708

A reproducible method to detect CD8 T cell mediated inhibition of HIV production from naturally infected CD4 cells.

M A Hausner1, J V Giorgi, S Plaeger-Marshall.   

Abstract

CD8 T lymphocytes are an important component of the host immune response to human immunodeficiency virus (HIV). To characterize CD8 cell function, we have studied the in vitro phenomenon of CD8 cell-mediated inhibition of HIV replication from autologous, naturally infected CD4 cells. We describe here a reproducible assay of CD8 T cell-mediated inhibition in HIV-infected individuals. The method involves the use of a commercially available cell separation system and anti-CD3 monoclonal antibody to stimulate CD4 cells to produce HIV. Using this technique, we were able to detect HIV production from the CD4 cells of 25 of 27 HIV-infected individuals who had not progressed to AIDS. Further, in vitro CD8 cell-mediated inhibition of HIV production was noted in all of the 25 subjects whose CD4 cells produced viral p24 antigen. This assay may be useful as an in vitro correlate of protective immunity to HIV, with potential application for assessing disease progression, therapeutic efficacy, and immune mechanisms in HIV disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093708     DOI: 10.1016/0022-1759(93)90085-l

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  A semiquantitative assay for CD8+ T-cell-mediated suppression of human immunodeficiency virus type 1 infection.

Authors:  Y Chen; C Rinaldo; P Gupta
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

2.  Autologous CD4/CD8 co-culture assay: a physiologically-relevant composite measure of CD8+ T lymphocyte function in HIV-infected persons.

Authors:  Steven R Fauce; Otto O Yang; Rita B Effros
Journal:  J Immunol Methods       Date:  2007-08-08       Impact factor: 2.303

3.  Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum.

Authors:  R E Dickover; E M Garratty; S Plaeger; Y J Bryson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor.

Authors:  K Grovit-Ferbas; J Ferbas; V Gudeman; S Sadeghi; M B Goetz; J V Giorgi; I S Chen; W A O'Brien
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.